Francis J Lunger
CIK 1191268 · Voir sur SEC EDGAR ↗
Dirigeant
Première déclaration SEC: 1 octobre 2010 · Dernier: 1 octobre 2010
Sur cette page
Dirigeant chez
Transactions d'initiés
0 achats (P)
0 ventes (S)
Net:
$0
+ 94 transactions non-marché ci-dessous
12 derniers mois, basé sur les transactions ci-dessous
Variation du prix par rapport à la cotation actuelle, ajustée des divisions pour les actions d'entreprise depuis le dépôt — non comparée à un indice de référence, non annualisée, non pondérée par la taille
94 autres dépôts masqués
| Date | Ticker | Code | Actions | Prix | Valeur | Possédé après | Δ possédé | A/D | vs maintenant |
|---|---|---|---|---|---|---|---|---|---|
| 4 mars 2021 | XRAY | S | 7 600 | $59,04 | $448 704 | 25 264 Direct | -23,13% | Cédé | -81,5% (prix au 2026-08-20) |
| 13 novembre 2017 | XRAY | S | 8 900 | $65,90 | $586 510 | 11 374 Direct | -43,90% | Cédé | -83,4% (prix au 2026-08-20) |
| 22 février 2017 | XRAY | S | 481 | $62,42 | $30 024 | 13 829 Direct | -3,36% | Cédé | -82,5% (prix au 2026-08-20) |
| 22 février 2017 | XRAY | S | 3 119 | $62,42 | $194 688 | 10 710 Direct | -22,55% | Cédé | -82,5% (prix au 2026-08-20) |
| 22 février 2017 | XRAY | S | 2 147 | $62,42 | $134 016 | 8 563 Direct | -20,05% | Cédé | -82,5% (prix au 2026-08-20) |
| 4 novembre 2014 | XRAY | S | 9 160 | $50,90 | $466 244 | 5 231 Direct | -63,65% | Cédé | -78,5% (prix au 2026-08-20) |
Affichage des 100 dernières transactions sur 200
P = Achat sur le marché · S = Vente · A = Attribution/prix · M = Exercice d'option · G = Don · F = Retenue d'impôt
Les transactions d'initiés ne constituent pas une recommandation ; les ventes sont souvent motivées par des raisons de liquidité ou fiscales.
Participations dans des produits dérivés (Formulaire 4 Tableau II)
Options, RSUs et titres convertibles déclarés dans le Formulaire 4 Tableau II.
| Date | Ticker | Titre | Sous-jacent | Prix d'exercice | Expiration | Actions | A/D |
|---|---|---|---|---|---|---|---|
| 9 avril 2021 | XRAY | Phantom Stock (Directors' Deferred Compensation) DDC | Common Stock (13) | — | — | 13 | Acquis |
| 4 mars 2021 | XRAY | Stock Option (Right to Buy) | Common Stock (7 600) | $38,57 | 25 mai 2021 | 7 600 | Cédé |
| 8 janvier 2021 | XRAY | Phantom Stock (Directors' Deferred Compensation) DDC | Common Stock (18) | — | — | 18 | Acquis |
| 9 octobre 2020 | XRAY | Phantom Stock (Directors' Deferred Compensation) DDC | Common Stock (23) | — | — | 23 | Acquis |
| 10 juillet 2020 | XRAY | Phantom Stock (Directors' Deferred Compensation) DDC | Common Stock (26) | — | — | 26 | Acquis |
| 13 avril 2020 | XRAY | Phantom Stock (Directors' Deferred Compensation) DDC | Common Stock (26) | — | — | 26 | Acquis |
| 10 janvier 2020 | XRAY | Phantom Stock (Directors' Deferred Compensation) DDC | Common Stock (18) | — | — | 18 | Acquis |
| 12 avril 2019 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (18) | — | — | 18 | Acquis |
| 11 janvier 2019 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (23) | — | — | 23 | Acquis |
| 12 octobre 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (47) | — | — | 47 | Acquis |
| 27 juillet 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (1 196) | $39,39 | 28 juillet 2018 | 1 196 | Cédé |
| 13 juillet 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (20) | — | — | 20 | Acquis |
| 23 mai 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (8 500) | $46,50 | 23 mai 2028 | 8 500 | Acquis |
| 13 avril 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (19) | — | — | 19 | Acquis |
| 12 janvier 2018 | XRAY | RSU (Restricted Stock Unit) | Common Stock (4) | — | — | 4 | Acquis |
| 29 décembre 2017 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (14) | — | — | 14 | Acquis |
| 13 novembre 2017 | XRAY | Stock Option (Right to Buy) | Common Stock (8 900) | $35,91 | 11 mai 2020 | 8 900 | Cédé |
| 13 octobre 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (4) | — | — | 4 | Acquis |
| 29 septembre 2017 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (16) | — | — | 16 | Acquis |
| 14 juillet 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (4) | — | — | 4 | Acquis |
| 30 juin 2017 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (14) | — | — | 14 | Acquis |
| 24 mai 2017 | XRAY | Stock Option (Right to Buy) | Common Stock (7 300) | $62,73 | 24 mai 2027 | 7 300 | Acquis |
| 21 mai 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 412) | — | — | 1 412 | Cédé |
| 14 avril 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | — | — | 6 | Acquis |
| 31 mars 2017 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (15) | — | — | 15 | Acquis |
| 22 février 2017 | XRAY | Stock Option | Common Stock (481) | $36,49 | 31 juillet 2017 | 481 | Cédé |
| 22 février 2017 | XRAY | Stock Option | Common Stock (3 119) | $41,07 | 13 mai 2018 | 3 119 | Cédé |
| 22 février 2017 | XRAY | Stock Option | Common Stock (2 147) | $41,07 | 13 mai 2018 | 2 147 | Cédé |
| 13 janvier 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | — | — | 5 | Acquis |
| 30 décembre 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (14) | — | — | 14 | Acquis |
| 14 octobre 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | — | — | 5 | Acquis |
| 4 octobre 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (14) | — | — | 14 | Acquis |
| 8 juillet 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | — | — | 5 | Acquis |
| 5 juillet 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (13) | — | — | 13 | Acquis |
| 25 mai 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 214) | — | 25 mai 2017 | 1 214 | Acquis |
| 25 mai 2016 | XRAY | Stock Option (Right to Buy) | Common Stock (5 800) | $61,77 | 25 mai 2026 | 5 800 | Acquis |
| 22 mai 2016 | XRAY | Common Stock | Common Stock (1 593) | — | 22 mai 2016 | 1 593 | Cédé |
| 22 mai 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 590) | — | 22 mai 2016 | 1 590 | Cédé |
| 8 avril 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | — | — | 6 | Acquis |
| 22 mars 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (13) | — | — | 13 | Acquis |
| 8 janvier 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | — | — | 5 | Acquis |
| 15 décembre 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (13) | — | — | 13 | Acquis |
| 9 octobre 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | — | — | 6 | Acquis |
| 22 septembre 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (14) | — | — | 14 | Acquis |
| 10 juillet 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | — | — | 6 | Acquis |
| 23 juin 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (14) | — | — | 14 | Acquis |
| 23 mai 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 739) | $51,86 | — | 1 739 | Cédé |
| 21 mai 2015 | XRAY | Stock Option | Common Stock (6 700) | $52,61 | 21 mai 2025 | 6 700 | Acquis |
| 21 mai 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 426) | — | — | 1 426 | Acquis |
| 10 avril 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | — | — | 7 | Acquis |
| 24 mars 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (13) | — | — | 13 | Acquis |
| 9 janvier 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | — | — | 6 | Acquis |
| 23 décembre 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (13) | — | — | 13 | Acquis |
| 4 novembre 2014 | XRAY | Stock Option | Common Stock (9 160) | $29,70 | 12 mai 2019 | 9 160 | Cédé |
| 10 octobre 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | — | — | 7 | Acquis |
| 23 septembre 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (15) | — | — | 15 | Acquis |
| 11 juillet 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | — | — | 7 | Acquis |
| 24 juin 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (14) | — | — | 14 | Acquis |
| 25 mai 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (909) | $46,90 | — | 909 | Cédé |
| 21 mai 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 390) | — | — | 1 390 | Acquis |
| 21 mai 2014 | XRAY | Stock Option | Common Stock (6 500) | $46,77 | 21 mai 2024 | 6 500 | Acquis |
| 24 mars 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (15) | — | — | 15 | Acquis |
| 10 janvier 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | — | — | 5 | Acquis |
| 26 décembre 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (13) | — | — | 13 | Acquis |
| 9 décembre 2013 | XRAY | Stock Option | Common Stock (18 000) | $28,10 | 11 mai 2015 | 18 000 | Cédé |
| 11 octobre 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | — | — | 6 | Acquis |
| 24 septembre 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (15) | — | — | 15 | Acquis |
| 12 juillet 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | — | — | 6 | Acquis |
| 25 juin 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (16) | — | — | 16 | Acquis |
| 22 mai 2013 | XRAY | Stock Option | Common Stock (6 200) | $41,47 | 22 mai 2023 | 6 200 | Acquis |
| 22 mai 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 567) | — | — | 1 567 | Acquis |
| 11 mai 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 120) | — | — | 1 120 | Cédé |
| 12 avril 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | $0,00 | — | 6 | Acquis |
| 11 avril 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | — | — | 6 | Acquis |
| 22 mars 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (13) | — | — | 13 | Acquis |
| 11 janvier 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | — | — | 5 | Acquis |
| 20 décembre 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (14) | — | — | 14 | Acquis |
| 12 octobre 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | — | — | 5 | Acquis |
| 24 septembre 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (15) | — | — | 15 | Acquis |
| 13 juillet 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (3) | $37,81 | — | 3 | Acquis |
| 25 juin 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (15) | — | — | 15 | Acquis |
| 23 mai 2012 | XRAY | Stock Option | Common Stock (6 900) | $38,02 | 23 mai 2022 | 6 900 | Acquis |
| 23 mai 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 710) | $0,00 | — | 1 710 | Acquis |
| 12 mai 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 367) | $0,00 | — | 1 367 | Cédé |
| 13 avril 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | $40,13 | — | 5 | Acquis |
| 23 mars 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (14) | — | — | 14 | Acquis |
| 10 janvier 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | $34,99 | — | 5 | Acquis |
| 22 décembre 2011 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (562) | $0,00 | — | 562 | Acquis |
| 10 octobre 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | $32,43 | — | 5 | Acquis |
| 26 septembre 2011 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (506) | — | — | 506 | Acquis |
| 28 juillet 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (178) | $0,00 | — | 178 | Cédé |
| 8 juillet 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (5) | $38,08 | — | 5 | Acquis |
| 8 juillet 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (54) | $38,08 | — | 54 | Acquis |
| 27 juin 2011 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (562) | — | — | 562 | Acquis |
| 25 mai 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (894) | $0,00 | — | 894 | Acquis |
| 25 mai 2011 | XRAY | Stock Option | Common Stock (7 600) | $38,57 | 25 mai 2021 | 7 600 | Acquis |
| 13 mai 2011 | XRAY | RSU (Restricted Stock Unit) Granted | Common Stock (773) | — | 13 mai 2018 | 773 | Cédé |
| 8 avril 2011 | XRAY | RSU (Restricted Stock Unit) Granted | Common Stock (5) | $36,49 | — | 5 | Acquis |
| 25 mars 2011 | XRAY | Directors' Deferred Comp (DDC) | Common Stock (468) | $36,14 | — | 468 | Acquis |
| 30 juillet 2010 | XRAY | RSU (Restricted Stock Unit) Granted | Common Stock (877) | — | 31 juillet 2017 | 877 | Cédé |
Affichage des 100 dernières transactions sur 154
Le prix d'exercice/conversion est vide lorsqu'il n'est pas applicable (par exemple, pour les RSUs).